
CVS Health® Survey Reveals Increasing Mental Health Concerns
A recent CVS Health Morning Consult survey indicates that mental health concerns among adults continue to rise significantly across the country. Key Findings: “Mental health became a top concern in 2020 and it has only risen since,” said Taft Parsons…

CVS Pharmacy® Launches Well Market™: A New Line of Crave-Worthy Consumables
CVS Pharmacy, the retail division of CVS Health®, has introduced Well Market™, a new store brand featuring a variety of snacks, beverages, and groceries. “Our goal at CVS Health is to be the most consumer-centric health care solutions company. With…

Prevention Efforts Foster Safer Communities
Prevention—activities designed to avoid substance misuse and mitigate its health and social consequences—is crucial for promoting mental health, preventing substance misuse, and supporting recovery efforts. CVS Health® is committed to national prevention initiatives, focusing on medication safety and education to…

College Students Report High-Risk Mental Health Issues 50% More Than High Schoolers
UnitedHealthcare’s second annual Student Behavioral Health Report reveals that college students are more likely to self-report experiencing high-risk mental or behavioral health concerns compared to high school students. Key findings highlight a significant disparity between college students’ self-reports and their…

Baxter Unveils Mission and Logo for Proposed Kidney Care Company Vantive
Baxter, a global medtech leader, announced today the mission and logo for its proposed kidney care and acute therapies company, to be named Vantive. The Vantive mission, “Extending Lives, Expanding Possibilities,” will guide and inspire the proposed company, which will…

Baxter Receives FDA Approval for Clinolipid (Lipid Injectable Emulsion) in Neonatal and Pediatric Use
Baxter, a global leader in nutrition therapy, today announced U.S. FDA approval for an expanded indication of Clinolipid (Lipid Injectable Emulsion) for use in pediatric patients, including preterm and term neonates. Clinolipid is Baxter’s proprietary mixed oil lipid emulsion designed…

Fresenius Divests Its Stake in Vamed
Following the announcement of the sale of Vamed’s rehabilitation business, the global healthcare group Fresenius has initiated a structured exit from its investment in Vamed. An Austrian consortium of construction companies, Porr and Strabag, has agreed to acquire Vamed’s operations…

Meridian in Michigan and Centene Foundation Award $1.1 Million Grant to Neighborhood Service Organization
Meridian, a leading managed care organization in Michigan and a wholly-owned subsidiary of Centene Corporation (NYSE: CNC), along with the Centene Foundation, the philanthropic arm of Centene Corporation, announced today a $1.1 million grant to the Neighborhood Service Organization (NSO),…

Chemed Corporation Scheduled to Speak at the Bank of America Securities Health Care Conference 2024
Chemed Corporation has announced its participation in the Bank of America Securities Health Care Conference 2024, scheduled for Tuesday, May 14, 2024, at 1:40 PM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be livestreamed and…

DaVita Recognizes 54 Exceptional Nephrology Nurses with DAISY Awards
DaVita, a prominent provider of kidney care services, proudly announced today that 54 of its nephrology nurses have been honored with the prestigious DAISY Award® for Extraordinary Nurses during National Nurses Week. This accolade is part of The DAISY Foundation’s…

Fresenius Raises Fiscal 2024 Outlook Following Strong First Quarter Performance
Michael Sen, CEO of Fresenius, expressed satisfaction with the company’s performance, citing an impressive start to the year. Sen attributed this success to the company’s intensified focus on Fresenius Kabi and Fresenius Helios, which he believes is yielding positive results.…

Fresenius Sells Its Stake in Investment Firm Vamed
Fresenius, a global healthcare conglomerate, has announced its decision to divest from Investment Company Vamed following the sale of Vamed’s rehabilitation business. An Austrian consortium comprising construction companies Porr and Strabag has agreed to purchase Vamed’s operations in its native…
